Innovative Trial Designs Are 'Life And Death Matter' For Pharma, Amgen Tells US FDA
Amgen exec calls for more informal agency feedback and alignment between review divisions in understanding design methodologies.
Amgen exec calls for more informal agency feedback and alignment between review divisions in understanding design methodologies.